SecBot SecBot
EFFECT ·Filed Oct 2, 2026

INM

InMed Pharmaceuticals Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed24d 16h ago SEC9999999995-26-003126
IPO/offering going effective
Actionable Insight • Neutral

Monitor for the filing of the definitive proxy statement/prospectus and any subsequent shareholder vote to understand the terms and valuation of the proposed business combination.

DirectionNeutral
Confidencemedium
Horizonweeks
Latest settled — T+5d
INM ▲ +2.26% at T+5d
NEUTRAL call +2.26% · α vs SPY +1.10% · entry $1.33 → $1.36
Next anchor: T+20d in 4d
Latest observation: T+15 +8.65% FF3 residual α
Entry = T+0 close
Oct 2, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.67%
$1.33
settled 21d ago
T+5d
+2.26%
call +2.26% · α +1.10%
$1.36
settled 17d ago
T+20d
Pending
in 4d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

InMed Pharmaceuticals Inc. received SEC effectiveness on October 1, 2026, for its S-4 registration statement (File No. 333-297234). This allows the company to proceed with a business combination transaction involving its own securities. The effectiveness is a procedural milestone and does not provide details on the specific transaction or its financial terms.

Key Facts

  • Effectiveness date: October 1, 2026
  • Registration statement type: S-4 (business combination)
  • SEC File Number: 333-297234
  • Company: InMed Pharmaceuticals Inc. (Ticker: INM)
  • No financial terms, share counts, or transaction details disclosed in the filing

Financial Impact

No financial impact disclosed; S-4 effectiveness is a procedural step for a business combination transaction.

Risk Factors

  • Transaction terms may be dilutive to existing shareholders
  • Business combination may not close as planned
  • No financial details available to assess deal quality

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-003126
Document: 9999999995-26-003126-index.html9999999995-26-003126
Document: 9999999995-26-003126.txt9999999995-26-003126
16 reports for INM
Performance horizon
60% Hit rate @ T+20 6 of 10 directional calls Went positive at some point 9 of 11 best @ T+5▲ +19.19%Mar 20, 2026
Filters
Rows
Reports for INM — sortable, filterable
TypeNow
Oct 7, 2026
18d ago
SC 13G/A
BULLISH ★ 5/10
$1.33awaiting T+20—$1.59 (+19.55%)
Oct 2, 2026
24d ago
EFFECT
NEUTRAL ★ 3/10
$1.33awaiting T+20—$1.59 (+19.55%)
Sep 18, 2026
5w ago
8-K
BEARISH ★ 6/10
$1.38 $1.37▲ +1.06%▲ +0.15%$1.59 (−15.22%)
Sep 9, 2026
6w ago
425
NEUTRAL ★ 6/10
$1.31 $1.33▲ +1.53%▼ −0.60%$1.59 (+21.37%)
Jul 10, 2026
15w ago
8-K
BEARISH ★ 6/10
$1.57 $1.41▲ +10.19%▲ +13.38%$1.59 (−1.27%)
Jul 2, 2026
16w ago
S-4
BEARISH ★ 7/10
$1.56 $1.50▲ +3.85%▲ +3.43%$1.59 (−1.92%)
Jun 10, 2026
19w ago
Insider Cluster
BULLISH ★ 7/10
$1.58 $1.66▲ +5.06%▲ +3.17%$1.59 (+0.63%)
Jun 10, 2026
19w ago
8-K
NEUTRAL ★ 4/10
$1.51 $1.66▲ +9.93%▲ +6.31%$1.59 (+5.30%)
May 19, 2026
22w ago
425
MIXED ★ 7/10
$1.60 $1.49▼ −6.88%▼ −7.86%$1.59 (−0.62%)
May 19, 2026
22w ago
8-K
BULLISH ★ 8/10
$1.60 $1.49▼ −6.88%▼ −7.86%$1.59 (−0.62%)
Showing 10 of 16

US Market Status

Market Closed — Opens Tue (16h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 2, 2026